Prosecution Insights
Last updated: August 18, 2026

Examiner: HUI, SAN MING R

Tech Center 1600 • Art Units: 1615 1617 1621 1627 1628 1629

This examiner grants 59% of resolved cases

Performance Statistics

59.3%
Allow Rate
-0.7% vs TC avg
1,350
Total Applications
+20.0%
Interview Lift
1085
Avg Prosecution Days
Based on 1308 resolved cases, 2023–2026

Rejection Statute Breakdown

2.3%
§101 Eligibility
7.5%
§102 Novelty
47.1%
§103 Obviousness
20.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18739657 COMBINATION Non-Final OA Novartis AG
17086409 PRODRUG COMPOSITIONS AND METHODS OF TREATMENT Final Rejection AQUESTIVE THERAPEUTICS, INC.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month